A positive trend for OS was observed (HR = 0.800; 95% CI: 0.637–1.003), though not yet statistically significant.
← all excerpts
A Systematic Review of Major Advances in Breast Cancer Therapeutics in 2025: Synthesis of Conference and Published Evidence.
1
—
—